| scholarly article | Q13442814 |
| P50 | author | Stefan D. Anker | Q30310195 |
| Michael A Gatzoulis | Q107217557 | ||
| P2093 | author name string | Wei Li | |
| Andrew J S Coats | |||
| Michael Kemp | |||
| Rakesh Sharma | |||
| Aidan P Bolger | |||
| Paul R Kalra | |||
| Marjolein Leenarts | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| chronic heart failure | Q11829287 | ||
| congenital disorder | Q727096 | ||
| P304 | page(s) | 92-99 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease | |
| P478 | volume | 106 |
| Q95421375 | Q95421375 |
| Q90452469 | Abdominal Skeletal Muscle Index as a Potential Novel Biomarker in Adult Fontan Patients |
| Q36229049 | Ambient temperature and biomarkers of heart failure: a repeated measures analysis |
| Q81028941 | Aminoterminal brain natriuretic peptide levels in children and adolescents after Fontan operation correlate with congestive heart failure |
| Q34796161 | Angiopoietin-2 in adults with congenital heart disease and heart failure |
| Q37076278 | Applying heart failure guidelines to adult congenital heart disease patients |
| Q34217527 | Asymmetrical dimethylarginine--more sensitive than NT-proBNP to diagnose heart failure in adults with congenital heart disease. |
| Q48237778 | B-type natriuretic peptide in cardiovascular disease |
| Q48717830 | B-type natriuretic peptide in children with atrial or ventricular septal defect: a cardiac catheterization study |
| Q44426914 | Bilateral lung transplantation for pediatric idiopathic pulmonary arterial hypertension: a multi-center experience |
| Q38259359 | Biomarkers in congenital heart disease |
| Q38113254 | Biomarkers in congenital heart disease: do natriuretic peptides hold the key? |
| Q48225101 | Body composition, appetite-related hormones, adipocytokines, and heart failure in adult patients with congenital heart disease: A preliminary study |
| Q33792556 | Cardiac adrenergic control and atrial fibrillation |
| Q35932382 | Cardiac cachexia |
| Q35138063 | Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited |
| Q36943418 | Chronic myocardial infarction promotes atrial action potential alternans, afterdepolarizations, and fibrillation |
| Q41216150 | Collagen turnover biomarkers and systemic right ventricle remodeling in adults with previous atrial switch procedure for transposition of the great arteries |
| Q46449626 | Comparison of segmental and global systemic ventricular function at rest and during dobutamine stress between patients with transposition and congenitally corrected transposition |
| Q47764828 | Comparison of the 6-minute walk test with established parameters for assessment of cardiopulmonary capacity in adults with complex congenital cardiac disease |
| Q41813913 | Congenital Heart Defects in Adults : A Field Guide for Cardiologists. |
| Q45030835 | Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. |
| Q38825516 | Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease |
| Q37394539 | Direct inotropic effects of exogenous and endogenous urotensin-II: divergent actions in failing and nonfailing human myocardium |
| Q52643350 | Effect of 6-min Walk Test on pro-BNP Levels in Patients with Pulmonary Arterial Hypertension. |
| Q40552256 | Effect of hypertension at presentation on prognosis in patients with dilated cardiomyopathy presenting with normal renal angiogram |
| Q36183312 | Effect of nucleoprotein factor-kB (NF-κB) in endothelial cells during high blood flow-associated pulmonary vascular remodeling on vasoactive substances adrenomedullin and prostacyclin |
| Q89762996 | Effects of Exercise Training in Postoperative Patients With Congenital Heart Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| Q57294005 | Effects of Pulmonary Hypertension and Right Ventricular Function in Short and Long-Term Kidney Function |
| Q33223037 | Effects of combined inhibition of the Na+-H+ exchanger and angiotensin-converting enzyme in rats with congestive heart failure after myocardial infarction |
| Q55234336 | Effects of eplerenone on markers of myocardial fibrosis, 6-minute walk distance, and quality of life in adults with tetralogy of Fallot and complete transposition of the great arteries. |
| Q73668684 | Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease |
| Q79259613 | Elevation of plasmatic endothelin in patients with heart failure |
| Q41689389 | Elimination of Transcoarctation Pressure Gradients Has No Impact on Left Ventricular Function or Aortic Shear Stress After Intervention in Patients With Mild Coarctation. |
| Q36570852 | Endothelin and endothelin receptor antagonism in portopulmonary hypertension |
| Q43019188 | Enhanced prothrombin formation and platelet activation in Chinese patients after transcatheter closure of atrial septal defect |
| Q47302655 | Enlarged right ventricular size at 11 years' follow-up after closure of secundum-type atrial septal defect in children |
| Q35954745 | Epoprostenol treatment in children with severe pulmonary hypertension |
| Q41203768 | Evaluation of exercise capacity with cardiopulmonary exercise testing and BNP levels in adult patients with single or systemic right ventricles |
| Q43119833 | Evidence-based management of right heart failure: a systematic review of an empiric field |
| Q36319305 | Exercise testing in adults after repair of aortic coarctation: evaluation of cardiopulmonary exercise capacity and B-type natriuretic protein levels. |
| Q36589148 | Exocytotic fusion pores are composed of both lipids and proteins |
| Q46542056 | GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure |
| Q38069566 | Heart failure associated with adult congenital heart disease |
| Q44030613 | Heart failure in adult congenital heart disease |
| Q89932559 | Heart failure in single right ventricle congenital heart disease: physiological and molecular considerations |
| Q36352006 | Heart failure therapy in children |
| Q39005911 | Heart transplantation in adult congenital heart disease |
| Q37993155 | Heart transplantation in adults with end-stage congenital heart disease. |
| Q37595543 | Incidence of new onset atrial fibrillation in patients with permanent pacemakers and the relation to the pacing mode. |
| Q48636609 | Increase in N-terminus-pro-B-type natriuretic peptide during exercise of patients with univentricular heart after a total cavopulmonary connection |
| Q35047455 | Inhibition of Na+-H+ exchange by cariporide reduces inflammation and heart failure in rabbits with myocardial infarction |
| Q53302230 | International Society for Adult Congenital Cardiac Disease: An introduction to the readership and an invitation to join |
| Q49555073 | JNK and NF-κB signaling pathways are involved in cytokine changes in patients with congenital heart disease prior to and after transcatheter closure |
| Q35771730 | Left ventricular adaptation after atrial septal defect closure assessed by increased concentrations of N-terminal pro-brain natriuretic peptide and cardiac magnetic resonance imaging in adult patients |
| Q35206814 | Management of Adults with Operated Tetralogy of Fallot |
| Q58732003 | Management of Heart Failure in Adult Congenital Heart Disease |
| Q47249280 | Management of acute heart failure in adult patients with congenital heart disease |
| Q34646942 | Microvolt T wave alternans in adults with congenital heart diseases characterized by right ventricle pathology or single ventricle physiology: a case control study |
| Q35655721 | Myocardial factor revisited: The importance of myocardial fibrosis in adults with congenital heart disease |
| Q33735092 | Myocardial fibrosis in Eisenmenger syndrome: a descriptive cohort study exploring associations of late gadolinium enhancement with clinical status and survival |
| Q48249789 | NT-proBNP correlates with right heart haemodynamic parameters and volumes in patients with atrial septal defects |
| Q73342766 | Natriuretic peptide and echocardiography after operation of atrial septal defect |
| Q84196586 | Optimised rate-responsive pacing does not improve either right ventricular haemodynamics or exercise capacity in adults with a systemic right ventricle |
| Q35582802 | Periodic breathing as a feature of right heart failure in congenital heart disease |
| Q35441891 | Pheochromocytoma and paraganglioma in cyanotic congenital heart disease. |
| Q57821413 | Pheochromocytoma in Congenital Cyanotic Heart Disease |
| Q35561842 | Predicting Outcomes Using the Heart Failure Survival Score in Adults with Moderate or Complex Congenital Heart Disease |
| Q48089853 | Pro-brain natriuretic peptide as marker of cardiovascular or pulmonary causes of dyspnea in patients with terminal parenchymal lung disease |
| Q40013053 | Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricle physiology, and systemic morphologically right/left ventricles |
| Q36865094 | Pulmonary insufficiency is the nexus of late complications in tetralogy of Fallot |
| Q36150144 | Pulmonary insufficiency: preparing the patient with ventricular dysfunction for surgery |
| Q36003953 | Pulmonary regurgitation: not a benign lesion |
| Q34624729 | Quantification of Diffuse Myocardial Fibrosis and Its Association With Myocardial Dysfunction in Congenital Heart Disease |
| Q43912634 | Renal function of patients with a failing Fontan circuit undergoing total cavopulmonary revision surgery |
| Q37907134 | Right side of heart failure |
| Q48233248 | Right ventricular function and N-terminal pro-brain natriuretic peptide levels in adult patients with simple dextro-transposition of the great arteries |
| Q48779608 | Right ventricular function in grown-up patients after correction of congenital right heart disease |
| Q33153278 | Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension |
| Q42034500 | Role of β-blocker therapy in pediatric heart failure |
| Q48120766 | Secretion of A-type and B-type natriuretic peptides into the bloodstream and pericardial space in children with congenital heart disease |
| Q33786574 | Severe pulmonary arterial hypertension associated with congenital cardiac shunts: evolution under specific treatment |
| Q37233844 | Sleep-disordered breathing in patients with decompensated heart failure |
| Q37890176 | Stressor states and the cation crossroads |
| Q48299921 | Subclinical hypothyroidism in grown-up congenital heart disease patients |
| Q38364054 | Sympathetic nervous system activation and β-adrenoceptor blockade in right heart failure |
| Q36670794 | The Right Heart in Congenital Heart Disease, Mechanisms and Recent Advances |
| Q38267854 | The clinical anatomy of the right ventricle. |
| Q38066242 | The natriuretic peptides as biomarkers for adults with congenital heart disease |
| Q34561996 | The proposed role of plasma NT pro-brain natriuretic peptide in assessing cardiac remodelling in hypertensive African subjects |
| Q38888906 | The renin-angiotensin-aldosterone-system and right heart failure in congenital heart disease |
| Q33578032 | The right ventricle: biologic insights and response to disease |
| Q36644859 | The right ventricle: biologic insights and response to disease: updated |
| Q48899563 | The syndrome of cardiac failure in adults with congenitally corrected transposition. |
| Q37016157 | Transcatheter closure of intracardiac defects in adults |
| Q37859755 | Treatment of congenital heart disease: risk-reducing measures in young adults. |
| Q37023891 | Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology |
| Q34365069 | Usefulness of B-type natriuretic peptide (BNP) as a screen for left ventricular abnormalities in diabetes mellitus |
Search more.